• Home

  • Company

    • About Us
    • Team
    • Collaborations
  • Products

    • Oxygen Carrying Solutions
    • Hemopure
    • Oxyglobin
    • Quality & Manufacturing
  • Media

    • Other Media
  • Publications

  • Contact

  • More

    Use tab to navigate through the menu items.

    Media

    Search
    See us in the April 2020 Edition of Men’s Health
    • Apr 24, 2020

    See us in the April 2020 Edition of Men’s Health

    Hemoglobin Oxygen Therapeutics LLC Announces Multiple Presentations Using Hemopure® in Donor Livers
    • Jun 4, 2019

    Hemoglobin Oxygen Therapeutics LLC Announces Multiple Presentations Using Hemopure® in Donor Livers

    Hemopure Plays A Pivotal Role In A Pioneering Study Published in Nature
    • Apr 19, 2019

    Hemopure Plays A Pivotal Role In A Pioneering Study Published in Nature

    Preclinical Results on Hemopure in Kidneys Discarded for Human Transplantation
    • Apr 10, 2019

    Preclinical Results on Hemopure in Kidneys Discarded for Human Transplantation

    Updated Results From The Netherlands Leading Liver Transplant Hospital
    • Feb 13, 2019

    Updated Results From The Netherlands Leading Liver Transplant Hospital

    Record Number Of Liver Transplants At UMCG Due To New Perfusion Technique
    • Jan 21, 2019

    Record Number Of Liver Transplants At UMCG Due To New Perfusion Technique

    The National Institute For Health And Care Excellence Approves Organ Perfusion For Use On The NHS
    • Jan 16, 2019

    The National Institute For Health And Care Excellence Approves Organ Perfusion For Use On The NHS

    Hemopure® To Be Evaluated In Groundbreaking Clinical Study Of Trauma Patients
    • Nov 8, 2018

    Hemopure® To Be Evaluated In Groundbreaking Clinical Study Of Trauma Patients

    SU Awarded Contract To Direct Large Clinical Study In Trauma Resuscitation
    • Nov 1, 2018

    SU Awarded Contract To Direct Large Clinical Study In Trauma Resuscitation

    Hb02 Therapeutics’ Products Become Element #47 In The Periodic Table Of Disruptive Technologies
    • Sep 11, 2018

    Hb02 Therapeutics’ Products Become Element #47 In The Periodic Table Of Disruptive Technologies

    Desperately Ill Patients Will Get Better Access To Experimental Treatments Through New Effort
    • Jul 26, 2018

    Desperately Ill Patients Will Get Better Access To Experimental Treatments Through New Effort

    UF Dept. of Anesthesiology Features Hemopure as Part of an Expanding Blood Management Program
    • Jun 5, 2018

    UF Dept. of Anesthesiology Features Hemopure as Part of an Expanding Blood Management Program

    Red Blood Cell Substitutes
    • Feb 16, 2018

    Red Blood Cell Substitutes

    First Ever Human Liver Transplantation After Ex-Situ Normothermic Machine Perfusion Using Hemopure®
    • Oct 19, 2017

    First Ever Human Liver Transplantation After Ex-Situ Normothermic Machine Perfusion Using Hemopure®

    UMCG Makes Rejected Donor Liver Suitable For Transplantation
    • Oct 10, 2017

    UMCG Makes Rejected Donor Liver Suitable For Transplantation

    © 2022 Hemoglobin Oxygen Therapeutics LLC